Skip to main content
Yixintang Pharmaceutical Group Co., Ltd. logo

Yixintang Pharmaceutical Group Co., Ltd. — Investor Relations & Filings

Ticker · 002727 ISIN · CNE100001WJ8 LEI · 300300NE1YJT00E9JD69 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 2,825 across all filing types
Latest filing 2025-10-27 Governance Information
Country CN China
Listing Shenzhen Stock Exchange 002727

About Yixintang Pharmaceutical Group Co., Ltd.

https://www.hx8886.com

Yixintang Pharmaceutical Group Co., Ltd. operates an extensive network of retail pharmacies providing a broad spectrum of healthcare products and services. The company specializes in the distribution of Western pharmaceuticals, traditional Chinese medicine (TCM), medical equipment, and health supplements. Its operational model integrates physical storefronts with digital platforms to facilitate online-to-offline (O2O) services, including prescription fulfillment and health consultations. Key offerings include chronic disease management, professional pharmaceutical advice, and a diverse inventory of over-the-counter (OTC) medications. The company focuses on community-based health accessibility, utilizing a robust supply chain to ensure product quality and availability across its service regions.

Recent filings

Filing Released Lang Actions
累积投票制实施细则
Governance Information Classification · 95% confidence The document is titled "累积投票制实施细则" which translates to "Cumulative Voting System Implementation Rules". It details the procedures and rules for the election of directors using cumulative voting, including nomination, voting, and election principles. It references company bylaws, laws, and stock exchange rules, indicating it is a governance-related document. There is no financial data, no mention of financial results, no voting results announcement, and no indication of a meeting presentation or report publication. The content is about internal governance rules and procedures for board elections, which fits the Governance Information category.
2025-10-27 Chinese
重大信息内部保密制度
Governance Information Classification · 95% confidence The document is titled as an internal confidentiality system for material information of Yixintang Pharmaceutical Group Co., Ltd. It outlines definitions, scope, responsibilities, confidentiality rules, penalties, and other internal governance related to the handling of material information. There is no financial data, no report of financial results, no announcement of voting results, no management changes, no earnings data, no legal proceedings, no capital changes, no merger or acquisition details, and no regulatory filings or certifications. The document is a detailed internal policy document related to governance and compliance on material information confidentiality. This fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices. The document length is sufficient and the content is substantive, not a mere announcement or certification. Therefore, the classification is CGR with high confidence.
2025-10-27 Chinese
关于修订《公司章程》的公告
Governance Information Classification · 95% confidence The document is a detailed announcement regarding the revision of the company's Articles of Association (公司章程). It includes extensive legal and procedural content about corporate governance, shareholder meetings, board of directors, and related rules. The text references regulatory bodies such as the China Securities Regulatory Commission (中国证监会) and Shenzhen Stock Exchange (深交所), and discusses compliance with laws and listing rules. The document is not a financial report, earnings release, or audit report, nor is it a brief announcement or voting result. It is a governance-related document detailing internal company rules and governance practices. Therefore, the most appropriate classification is Governance Information (CGR). The document length (15,000 characters) and content depth support this classification with high confidence.
2025-10-27 Chinese
独立董事提名人声明与承诺（施谦）
Regulatory Filings Classification · 95% confidence The document is a formal statement and commitment by a nominator regarding the nomination of an independent director candidate for the company's board. It includes detailed declarations about the nominee's qualifications, compliance with laws and regulations, and independence criteria. There is no financial data, no report of financial performance, no voting results, no management changes announcement, and no mention of a meeting or shareholder vote results. The document is a regulatory compliance statement related to board nominations, which fits best under Regulatory Filings (RNS) as it does not fit other more specific categories like Board/Management Information (MANG) which typically announces actual changes rather than nomination statements.
2025-10-27 Chinese
关于召开2025年度第三次临时股东会的通知
AGM Information Classification · 100% confidence The document is a detailed notice about the convening of the 2025 third extraordinary general meeting of shareholders for the company 一心堂药业集团股份有限公司. It includes information about the meeting time, location, agenda items (such as election of board members and amendments to company bylaws), voting procedures (including cumulative voting), registration details, and proxy forms. The document is not a financial report, earnings release, or audit report. It is not a simple announcement of voting results but a full notice and materials related to the shareholder meeting itself. This fits the definition of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting or other shareholder meetings. The document length (7391 characters) and content confirm it is the meeting notice and related materials, not just an announcement or summary. Therefore, the correct classification is AGM Information (AGM-R).
2025-10-27 Chinese
第六届董事会2025年第六次独立董事专门会议审核意见
Board/Management Information Classification · 95% confidence The document is a formal opinion from the independent directors of the company's sixth board regarding the nomination of candidates for the seventh board of directors, both non-independent and independent directors. It references compliance with company law, securities law, and stock exchange regulations. The document is a meeting opinion or review related to board nominations and does not contain financial data, earnings, or audit information. It is not an announcement of voting results but a management/board-related document concerning board member nominations and approvals. Therefore, it fits best under Board/Management Information (MANG). The document length is short (1430 characters), and it is a detailed opinion rather than a brief announcement or certification, supporting the MANG classification.
2025-10-27 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.